THE I-PASS COMMUNICATION METHOD ON NURSE PERCEPTION OF HANDOVER QUALITY

April 25, 2026 updated by: Agnes Stephania Penu, Universitas Padjadjaran

THE EFFECTIVENESS OF THE I-PASS COMMUNICATION METHOD ON NURSE PERCEPTION OF HANDOVER QUALITY IN THE INPATIENT WARD OF WELAS ASIH HOSPITAL, WEST JAVA PROVINCE

The goal of this non-clinical study is to determine whether the I-PASS communication method influences the improvement of handover quality among nurses. The main questions it aims to answer are:

What are the perceptions of handover quality prior to implementing the I-PASS method? What are the perceptions of handover quality after using the I-PASS method? How do nurse characteristics (gender, age, education, employment status, length of service, and clinical nurse level) affect the improvement of handover quality perceptions when using the I-PASS method? What is the implementation retention of the I-PASS communication method? Is there a significant effect of the I-PASS communication method on nurses' perceptions of handover quality?

Participants will:

Participate in training sessions regarding the I-PASS communication method. Implement the I-PASS method during handover processes for two weeks. Complete questionnaires to assess handover quality.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Indonesia
    • West Java
      • Bandung, West Java, Indonesia, 40191
        • Welas Asih General Hospital West Java Province

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. General practitioner nurses who working in the internal ward
  2. General practitioner nurses with a minimum of 6 months of the clinical experience

Exclusion Criteria:

  1. Clinical nurse manager / leader who did not provide nursing care (e.g Head nurse)
  2. Nurses on leave

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training I-PASS handoff bundle
Partisipant in experimental arms will receive I-PASS handoff bundle into daily nursing process for 2 weeks
Other: Training I-PASS handoff bundle
The intervention proceeds of Training I-PASS handoff bundle in three phases: preparation, training, and evaluation. First, eligible nurses are recruited, provided with informed consent, and grouped by shifts. After a baseline assessment, participants undergo two 90-minute training sessions over two weeks. Next, the I-PASS method is implemented for 14 days, with compliance monitored through direct shift-based observations and checklists. Handover quality is measured via the Handover Evaluation Scale (HES) at three intervals: pre-test (baseline), mid-point (week two), and post-test (week three). Continuous researcher monitoring ensures protocol fidelity throughout the process.
No Intervention: SBAR
The control group continues to utilize the hospital's existing standard operating procedure, the SBAR (Situation, Background, Assessment, Recommendation) method, observed two weeks not training I-PASS handoff bundle

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Handover Quality
Time Frame: two weeks
Handover quality measure by the handover evaluation scale instrument
two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universitas Padjadjaran

Investigators

  • Principal Investigator: Agnes Stephania Penu, BSN, MSc, RN, Faculty of Nursing, Universitas Padjadjaran

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2026

Primary Completion (Actual)

April 15, 2026

Study Completion (Actual)

April 15, 2026

Study Registration Dates

First Submitted

April 25, 2026

First Submitted That Met QC Criteria

April 25, 2026

First Posted (Actual)

May 1, 2026

Study Record Updates

Last Update Posted (Actual)

May 1, 2026

Last Update Submitted That Met QC Criteria

April 25, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NURS-202604.01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This research considers ethical values such as autonomy, confidentiality, beneficence, non- maleficence and justice

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Training I-PASS handoff bundle

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe